Related Experiment Video
Updated: Dec 31, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
DNA damage repair functions and targeted treatment in breast cancer
Chenfeng He1, Kosuke Kawaguchi2, Masakazu Toi1
1Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Abstract:
Cell DNA is continuously attacked by endogenous and exogenous agents, which causes DNA damage. During long-term evolution, complex defense systems for DNA damage repair are formed by cells to maintain genome stability. Defects in the DNA damage repair process may lead to various diseases, including tumors. Therefore, DNA damage repair systems have become a new anti-tumor drug target. To date, a number of inhibitors related to DNA damage repair systems have been developed, particularly for tumors with BRCA1 and BRCA2 mutations. Poly (ADP-ribose) polymerase inhibitors developed by synthetic lethality are widely used in individualized tumor therapy. In this review, we briefly introduce the mechanisms underlying DNA damage repair, particularly in breast cancer, and mainly focus on new treatments targeting the DNA damage repair pathway in breast cancer.
Insights
Cells constantly repair DNA damage to maintain genome stability, preventing diseases like cancer. Targeting DNA repair pathways, especially with poly (ADP-ribose) polymerase inhibitors, offers new anti-tumor strategies for breast cancer.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Cellular DNA is susceptible to damage from internal and external sources.
- Cells possess intricate DNA damage repair (DDR) systems crucial for genomic stability.
- Defects in DDR pathways are implicated in various diseases, notably cancer.
Purpose of the Study:
- To review the mechanisms of DNA damage repair.
- To focus on novel therapeutic strategies targeting DDR pathways in breast cancer.
- To highlight the role of DDR in cancer development and treatment.
Main Methods:
- Literature review of DNA damage repair mechanisms.
- Analysis of current therapeutic strategies targeting DDR pathways.
- Focus on breast cancer-specific DDR and treatment approaches.
Main Results:
- DNA damage repair is essential for preventing genomic instability and disease.
- Inhibitors targeting DDR pathways, such as poly (ADP-ribose) polymerase inhibitors, show promise in cancer therapy.
- BRCA1/2-mutated tumors are particularly responsive to DDR-targeted therapies.
Conclusions:
- DNA damage repair pathways represent a significant target for anti-cancer drug development.
- Targeted therapies exploiting synthetic lethality in DDR pathways are advancing individualized cancer treatment.
- Further research into DDR mechanisms can lead to more effective breast cancer therapies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
DNA Damage can Stall the Cell Cycle

